Ricinine (76) analogues exert anti-cancer activity by down-regulating protein tyrosine phosphatase (PTP1B) and cyclooxygenase-2 (COX-2) enzymes through highly activated PTP1B protein [113]. This evidence concerns the gene PTPN1 and cancer.